Simvastatin Induces Delayed Apoptosis Through Disruption of Glycolysis and Mitochondrial Impairment in Neuroblastoma Cells
Simvastatin, a commonly used cholesterol‐lowering drug, inhibits the mevalonate pathway involved in the synthesis of the mitochondrial electron carrier coenzyme Q10 (CoQ10), as well as other bioenergetics substrates. The purpose of this study was to investigate simvastatin exposure on mitochondrial...
Saved in:
Main Authors: | Crystal L. Kuzyk (Author), Colin C. Anderson (Author), James R. Roede (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triptolide Induces Leydig Cell Apoptosis by Disrupting Mitochondrial Dynamics in Rats
by: Linyan Lv, et al.
Published: (2021) -
Long non-coding ribonucleic acid SNHG18 induced human granulosa cell apoptosis via disruption of glycolysis in ovarian aging
by: Xuehan Zhao, et al.
Published: (2024) -
Simvastatin Induces Apoptosis but Attenuates Migration in SCAPs
by: Paak Rewthamrongsris, et al.
Published: (2024) -
9LB HIV-1 disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis in astrocyte
by: D.S. Ojeda, et al.
Published: (2016) -
Effects of L-dopa and p-coumaric acid combination on oxidative stress, DNA damage, and mitochondrial apoptosis in neuroblastoma cells
by: Nebiye Pelin Turker, et al.
Published: (2023)